(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 7.93% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.25%.
Caredx's revenue in 2024 is $297,084,000.On average, 3 Wall Street analysts forecast CDNA's revenue for 2024 to be $17,112,022,996, with the lowest CDNA revenue forecast at $16,982,282,576, and the highest CDNA revenue forecast at $17,247,037,416. On average, 3 Wall Street analysts forecast CDNA's revenue for 2025 to be $17,934,239,720, with the lowest CDNA revenue forecast at $17,076,687,190, and the highest CDNA revenue forecast at $18,467,441,201.
In 2026, CDNA is forecast to generate $20,032,237,239 in revenue, with the lowest revenue forecast at $20,032,237,239 and the highest revenue forecast at $20,032,237,239.